267 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback http://www.zacks.com/stock/news/256108/biotech-stock-roundup-geron-gains-on-interim-data-oncomed-slumps-on-pipeline-setback?cid=CS-ZC-FT-256108 Apr 12, 2017 - Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.
Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals http://www.zacks.com/stock/news/254822/zackscom-featured-highlights-ptc-covanta-holding-etsy-incyte-and-amag-pharmaceuticals?cid=CS-ZC-FT-254822 Mar 31, 2017 - Zacks.com featured highlights: PTC, Covanta Holding, Etsy, Incyte and AMAG Pharmaceuticals
5 Toxic Stocks to Get Rid Of or Play Short to Make Gains http://www.zacks.com/stock/news/254716/5-toxic-stocks-to-get-rid-of-or-play-short-to-make-gains?cid=CS-ZC-FT-254716 Mar 30, 2017 - Exaggerated price of toxic stocks can be attributed to either an irrational exuberance associated with them or some serious fundamental lacuna.
Incyte (INCY) Up 26.2% Since Earnings Report: Can It Continue? http://www.zacks.com/stock/news/253120/incyte-incy-up-262-since-earnings-report-can-it-continue?cid=CS-ZC-FT-253120 Mar 17, 2017 - Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals http://www.zacks.com/stock/news/253076/zackscom-featured-highlights-covanta-holding-etsy-ptc-incyte-and-vertex-pharmaceuticals?cid=CS-ZC-FT-253076 Mar 16, 2017 - Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex Pharmaceuticals
Biotech Stock Roundup: Amgen's Data on Repatha, Catalyst Soars on Firdapse Data http://www.zacks.com/stock/news/252975/biotech-stock-roundup-amgens-data-on-repatha-catalyst-soars-on-firdapse-data?cid=CS-ZC-FT-252975 Mar 16, 2017 - The biotech sector reacted favorably to President Donald Trump's pick for the top post in the FDA.
5 Toxic Stocks to Dump or Play Short to Make Gains http://www.zacks.com/stock/news/252843/5-toxic-stocks-to-dump-or-play-short-to-make-gains?cid=CS-ZC-FT-252843 Mar 15, 2017 - Unreasonably high price of toxic stocks is only short-lived as the intrinsic value of these stocks is lower than the current bloated price.
Agenus (AGEN) Reports Narrower-than-Expected Loss in Q4 http://www.zacks.com/stock/news/252407/agenus-agen-reports-narrower-than-expected-loss-in-q4?cid=CS-ZC-FT-252407 Mar 10, 2017 - Agenus Inc. (AGEN) reported fourth-quarter 2016 loss of 30 cents per share (including non-cash expenses), narrower than the Zacks Consensus Estimate of a loss of 33 cents but wider than the year-ago loss of 18 cents.
How Incyte Stock Became a Bull Market Star for Biotech Investors http://www.zacks.com/stock/news/252365/how-incyte-stock-became-a-bull-market-star-for-biotech-investors?cid=CS-ZC-FT-252365 Mar 10, 2017 - Incyte (INCY) tops the list of stocks that enjoyed a stupendous run in the last 8 years.
A Trip to 8-Year Bull Run: What's Up, What's Down http://www.zacks.com/stock/news/252331/a-trip-to-8-year-bull-run-whats-up-whats-down?cid=CS-ZC-FT-252331 Mar 09, 2017 - While all the three major indices more than tripled scaling multiple highs in recent months, Nasdaq has won the maximum in the eight-year bull run.

Pages: 1...2021222324252627

<<<Page 25>